Compare AAPG & PLUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AAPG | PLUS |
|---|---|---|
| Founded | 2009 | 1990 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.2B |
| IPO Year | N/A | 1996 |
| Metric | AAPG | PLUS |
|---|---|---|
| Price | $24.81 | $81.20 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $48.40 | N/A |
| AVG Volume (30 Days) | 2.3K | ★ 158.4K |
| Earning Date | 05-12-2026 | 05-21-2026 |
| Dividend Yield | N/A | ★ 1.22% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 4.08 |
| Revenue | N/A | ★ $2,068,789,000.00 |
| Revenue This Year | $332.66 | $19.83 |
| Revenue Next Year | N/A | $4.36 |
| P/E Ratio | ★ N/A | $20.10 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $18.55 | $57.14 |
| 52 Week High | $48.45 | $93.98 |
| Indicator | AAPG | PLUS |
|---|---|---|
| Relative Strength Index (RSI) | 50.65 | 60.04 |
| Support Level | $23.15 | $69.48 |
| Resistance Level | $25.23 | $81.72 |
| Average True Range (ATR) | 0.46 | 2.61 |
| MACD | 0.30 | 0.96 |
| Stochastic Oscillator | 59.10 | 74.46 |
Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.
ePlus Inc is a provider of technology solutions across the IT spectrum, spanning security, cloud, data center, networking, collaboration, AI, service provider, and critical infrastructure, and emerging solutions, to domestic and foreign organizations across all industry segments. Its solutions leverage a broad range of professional, consultative, and managed services across the technology spectrum. The company possesses top-level engineering certifications with a broad range of IT technologies that enable the company to offer multi-vendor IT solutions that are optimized for each of its customers' specific requirements. It also offers a wide portfolio of technology and other capital asset financing solutions to customers across commercial and government enterprises, designing programs.